title: Noradrenergic mechanisms involved in muscle relaxation: significance for the treatment of spasticity.
authors.forename: M
authors.initials: M
authors.lastname: Wiesendanger
authors.forename: M
authors.initials: M
authors.lastname: Corboz
authors.forename: A
authors.initials: A
authors.lastname: Palmeri
authors.forename: D F
authors.initials: DF
authors.lastname: Chen
authors.forename: C I
authors.initials: CI
authors.lastname: Palmer
mesh_terms: D000818:Animals; D003000:Clonidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008125:Locus Coeruleus / Q000187:drug effects* / Q000503:physiopathology; D009125:Muscle Relaxants, Central; D009128:Muscle Spasticity / Q000188:drug therapy* / Q000503:physiopathology; D009433:Neural Inhibition / Q000187:drug effects / Q000502:physiology; D009434:Neural Pathways / Q000187:drug effects / Q000503:physiopathology; D009638:Norepinephrine / Q000502:physiology*; D013116:Spinal Cord / Q000187:drug effects / Q000503:physiopathology
chemical_list: D009125:Muscle Relaxants, Central; C023754:tizanidine; D003000:Clonidine; D009638:Norepinephrine